Ironwood Pharmaceuticals, Inc.
IRWD
$1.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.60M | -37.39M | 2.26M | 3.65M | -860.00K |
| Total Depreciation and Amortization | 467.00K | 479.00K | 485.00K | 907.00K | 506.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.55M | 6.79M | 46.09M | 15.97M | 22.80M |
| Change in Net Operating Assets | -58.68M | 50.08M | -33.61M | -10.63M | 11.02M |
| Cash from Operations | -15.07M | 19.95M | 15.21M | 9.89M | 33.47M |
| Capital Expenditure | -2.00K | -31.00K | 0.00 | -16.00K | -58.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -31.00K | 0.00 | -16.00K | -58.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 150.00M |
| Total Debt Repaid | -- | -- | -15.00M | -25.00M | -200.00M |
| Issuance of Common Stock | 88.00K | 6.00K | 203.00K | 0.00 | 749.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -121.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -90.00K | -2.16M | -- |
| Cash from Financing | 88.00K | 6.00K | -14.89M | -27.16M | -49.37M |
| Foreign Exchange rate Adjustments | -647.00K | -7.00K | 21.00K | -26.00K | -51.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.63M | 19.92M | 348.00K | -17.31M | -16.02M |